Business Today, Gordon Brown, Britain, UK
Business Today
Crow's View by PB Jayakumar
Capping stent prices

The National Pharmaceutical Pricing Authority (NPPA) is seriously trying to regulate prices of stents to bring down angioplasty costs.

Soon Ranbaxy Laboratories will cease to exist as the company is merging with Sun Pharmaceutical Industries.
Vivek Talwar, a long-time executive with the Tata Group wields a new visiting card with an unusual designation - Chief Culture Officer.